Altered Glucagon and GLP-1 Responses to Oral Glucose in Children and Adolescents With Obesity and Insulin Resistance

被引:6
作者
Stinson, Sara Elizabeth [1 ]
Alzola, Ierai Fernandez de Retana [1 ]
Hovendal, Emilie Damgaard Brunner
Lund, Morten Asp Vonsild [2 ,3 ]
Fonvig, Cilius Esmann [1 ,2 ,4 ]
Holm, Louise Aas [1 ,2 ]
Jonsson, Anna Elisabet [1 ]
Frithioff-Bojsoe, Christine [1 ,2 ]
Christiansen, Michael [3 ,5 ]
Pedersen, Oluf [1 ,6 ]
Angquist, Lars [1 ]
Sorensen, Thorkild I. A. [1 ,7 ]
Holst, Jens Juul [1 ,3 ]
Hartmann, Bolette [1 ,3 ]
Holm, Jens-Christian [1 ,2 ,9 ]
Hansen, Torben [1 ,8 ]
机构
[1] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Fac Hlth & Med Sci, DK-2200 Copenhagen, Denmark
[2] Holbaek Cent Hosp, Accredited European Ctr Obes Management, Dept Pediat, Childrens Obes Clin, DK-4300 Holbaek, Denmark
[3] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, DK-2200 Copenhagen, Denmark
[4] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, DK-2200 Copenhagen, Denmark
[5] Statens Serum Inst, Dept Congenital Disorders, DK-2300 Copenhagen, Denmark
[6] Herlev Gentofte Univ Hosp, Ctr Clin Metab Res, DK-2900 Copenhagen, Denmark
[7] Univ Copenhagen, Fac Hlth & Med Sci, Dept Publ Hlth, DK-1353 Copenhagen, Denmark
[8] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Fac Hlth & Med Sci, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark
[9] Holbaek Cent Hosp, Accredited European Ctr Obes Management, Dept Paediat, Childrens Obes Clin, Smedelundsgade 60, DK-4300 Holbaek, Denmark
关键词
adolescent; child; glucagon; GLP-1; GIP; obesity; BETA-CELL FUNCTION; SENSITIVITY INDEXES; INCRETIN HORMONES; DISPOSITION INDEX; REFERENCE VALUES; TOLERANCE TEST; SECRETION; POLYPEPTIDE; SUPPRESSION; VALIDATION;
D O I
10.1210/clinem/dgad728
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Pediatric obesity is characterized by insulin resistance, yet it remains unclear whether insulin resistance contributes to abnormalities in glucagon and incretin secretion.Objective To examine whether fasting and stimulated glucagon, glucagon-like peptide-1 (GLP-1), and glucose-dependent insulinotropic polypeptide (GIP) concentrations differ between children and adolescents with obesity and insulin resistance (OIR), obesity and normal insulin sensitivity (OIS), and controls with normal weight (NW).Methods 80 (34 boys) children and adolescents, aged 7-17 years with OIR (n = 22), OIS (n = 22), and NW (n = 36) underwent an oral glucose tolerance test with measurements of serum insulin, plasma glucose, glucagon, total GLP-1, and total GIP. Homeostatic model assessment of insulin resistance (HOMA-IR), single point insulin sensitivity estimator (SPISE), Matsuda index, insulinogenic index (IGI), and oral disposition index (ODI) were calculated.Results Fasting concentrations of glucagon and GLP-1 were higher in the OIR group, with no significant differences for GIP. The OIR group had higher glucagon total area under the curve (tAUC0-120) and lower GLP-1 incremental AUC (iAUC0-120), with no significant differences in GIP iAUC0-120. Higher fasting glucagon was associated with higher HOMA-IR, lower Matsuda index, lower SPISE, higher IGI, and higher plasma alanine transaminase, whereas higher fasting GLP-1 was associated with higher HOMA-IR, lower Matsuda index, and lower ODI. Higher glucagon tAUC0-120 was associated lower SPISE and lower Matsuda index, whereas lower GLP-1 iAUC0-120 was associated with a higher HOMA-IR, lower Matsuda index, and lower ODI.Conclusion Children and adolescents with OIR have elevated fasting concentrations of glucagon and GLP-1, higher glucagon and lower GLP-1 responses during an OGTT compared to those with OIS and NW. In contrast, individuals with OIS have similar hormone responses to those with NW.
引用
收藏
页码:1590 / 1600
页数:11
相关论文
共 50 条
[41]   Oral glucose tolerance test curve shape in Mexican children and adolescents with and without obesity [J].
Evia-Viscarra, Maria Lola ;
Jacobo-Tovar, Emmanuel ;
Meneses-Rojas, Luis Fernando ;
Guardado-Mendoza, Rodolfo .
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2024, 37 (10) :850-858
[42]   Release of glucagon-like peptide 1 (GLP-1 [7-36 amide]), Gastric Inhibitory Polypeptide (GIP) and insulin in response to oral glucose after upper and lower intestinal resections [J].
Nauck, MA ;
Siemsgluss, J ;
Orskov, C ;
Holst, JJ .
ZEITSCHRIFT FUR GASTROENTEROLOGIE, 1996, 34 (03) :159-166
[43]   GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO Study [J].
Faerch, Kristine ;
Torekov, Signe S. ;
Vistisen, Dorte ;
Johansen, Nanna B. ;
Witte, Daniel R. ;
Jonsson, Anna ;
Pedersen, Oluf ;
Hansen, Torben ;
Lauritzen, Torsten ;
Sandbaek, Annelli ;
Holst, Jens Juul ;
Jorgensen, Marit E. .
DIABETES, 2015, 64 (07) :2513-2525
[44]   A New Endoscopically Implantable Device (SatiSphere) for Treatment of Obesity-Efficacy, Safety, and Metabolic Effects on Glucose, Insulin, and GLP-1 Levels [J].
Sauer, Nina ;
Roesch, Thomas ;
Pezold, Jennifer ;
Reining, Franziska ;
Anders, Mario ;
Groth, Stefan ;
Schachschal, Guido ;
Mann, Oliver ;
Aberle, Jens .
OBESITY SURGERY, 2013, 23 (11) :1727-1733
[45]   Glucagon-like peptide-1 (GLP-1) receptor agonists, obesity and psoriasis: diabetes meets dermatology [J].
D. J. Drucker ;
C. F. Rosen .
Diabetologia, 2011, 54 :2741-2744
[46]   Glucagon-like peptide-1 (GLP-1) receptor agonists, obesity and psoriasis: diabetes meets dermatology [J].
Drucker, D. J. ;
Rosen, C. F. .
DIABETOLOGIA, 2011, 54 (11) :2741-2744
[47]   Fasting and oral glucose-stimulated levels of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are highly familial traits [J].
Gjesing, A. P. ;
Ekstrom, C. T. ;
Eiberg, H. ;
Urhammer, S. A. ;
Holst, J. J. ;
Pedersen, O. ;
Hansen, T. .
DIABETOLOGIA, 2012, 55 (05) :1338-1345
[48]   Plasma glucagon-like peptide-1 (GLP-1) responses to duodenal fat and glucose infusions in lean and obese men [J].
Feinle, C ;
Chapman, IM ;
Wishart, J ;
Horowitz, M .
PEPTIDES, 2002, 23 (08) :1491-1495
[49]   The effects of fiber enrichment of pasta and fat content on gastric emptying, GLP-1, glucose, and insulin responses to a meal [J].
Frost, GS ;
Brynes, AE ;
Dhillo, WS ;
Bloom, SR ;
McBurney, MI .
EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2003, 57 (02) :293-298
[50]   Healthcare professionals' perceptions and management of obesity & knowledge of glucagon, GLP-1, GIP receptor agonists, and dual agonists [J].
Garvey, W. Timothy ;
Mahle, Cathy D. ;
Bell, Trevor ;
Kushner, Robert F. .
OBESITY SCIENCE & PRACTICE, 2024, 10 (03)